Hint mode is switched on Switch off

PRF Technologies, ordinary share
PRFX, IL0011651580

Add a stock to WL
Choose all Reset all
PRF Technologies, сountry — Israel
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
PRF Technologies Ltd is an Israel-based company engaged primarily in pharmaceutical sector. The Company is a producer of speciality pharmaceuticals as well as energy analytics powered by artificial intelligence (AI). The Firm develops reformulated and sustainedrelease ...
PRF Technologies Ltd is an Israel-based company engaged primarily in pharmaceutical sector. The Company is a producer of speciality pharmaceuticals as well as energy analytics powered by artificial intelligence (AI). The Firm develops reformulated and sustainedrelease drugdelivery platforms that combine proven generic medicines with proprietary extendedrelease systems to improve patient outcomes. One of the Company's products is PRF110 - a ropivacainebased formulation designed to deliver localised, extended postoperative analgesia. The Company also advances OcuRingTD, a bioerodible drugrelease ring integrated with intraocular lenses for continuous delivery of medications in cataract surgery.In the energy analytics sector the Company operates DeepSolar platform that provides AIpowered monitoring, forecasting, and optimisation tools for solar asset performance.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    PRF Technologies Ltd.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    PRFX
  • Placement
    01.09.2020
  • Lock up period
    180
  • Number of papers
    2,500,000
  • Volume of raised funds
    20 mln USD
  • Placement share
    28.06%
  • Final placement price
    8 USD
  • Price change since placement date
    -82.25%
  • By capitalization
    71.28 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    PRFX
  • Placement
    17.04.2024
  • Lock up period
    180
  • Number of papers
    7,026,243
  • Volume of raised funds
    0.36 mln USD
  • Placement share
    6.37%
  • Final placement price
    0.8 USD
  • Price change since placement date
    77.51%
  • By capitalization
    5.62 mln USD

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
2021
IV q eng
2020
IV q eng
Show all Hide

Related Stock indices

Indicators

Holders

Industry Leaders

Registration is required to get access.